ArticleEClinicalMedicine2024

Safety and immunogenicity of CD40.HIVRI.Env, a dendritic cell-based HIV vaccine, in healthy HIV-uninfected adults: a first-in-human randomized, placebo-controlled, dose-escalation study (ANRS VRI06).

Yves Levy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.